ARK Genomic Revolution ETF $ARKG Shares Newly Acquired by Canal Insurance CO

Canal Insurance CO purchased a new stake in ARK Genomic Revolution ETF (BATS:ARKG) in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The fund purchased 120,000 shares of the company’s stock, valued at approximately $6,517,000. ARK Genomic Revolution ETF makes up 1.5% of Canal Insurance CO’s investment portfolio, making the stock its 20th largest holding. Canal Insurance CO owned about 0.27% of ARK Genomic Revolution ETF as of its most recent filing with the SEC.

A number of other large investors also recently bought and sold shares of the business. Gimbal Financial purchased a new position in ARK Genomic Revolution ETF during the third quarter worth approximately $6,478,000. Midwest Financial Partners Investments Inc. grew its holdings in ARK Genomic Revolution ETF by 2.1% in the first quarter. Midwest Financial Partners Investments Inc. now owns 209,416 shares of the company’s stock valued at $5,533,000 after purchasing an additional 4,230 shares during the period. Baird Financial Group Inc. increased its position in shares of ARK Genomic Revolution ETF by 0.3% in the second quarter. Baird Financial Group Inc. now owns 73,722 shares of the company’s stock valued at $3,101,000 after buying an additional 255 shares in the last quarter. Client First Investment Management LLC purchased a new stake in shares of ARK Genomic Revolution ETF in the second quarter valued at approximately $2,579,000. Finally, Himension Capital Singapore PTE. LTD. purchased a new stake in shares of ARK Genomic Revolution ETF in the first quarter valued at approximately $2,250,000.

ARK Genomic Revolution ETF Trading Up 3.2%

Shares of ARKG stock traded up $1.50 during trading hours on Tuesday, hitting $48.87. 3,269,506 shares of the company’s stock were exchanged, compared to its average volume of 3,380,569. The firm has a 50 day moving average of $48.93 and a two-hundred day moving average of $39.66. ARK Genomic Revolution ETF has a fifty-two week low of $24.60 and a fifty-two week high of $58.83.

About ARK Genomic Revolution ETF

The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that targets companies involved in the genomics industry. ARKG was launched on Oct 31, 2014 and is managed by ARK.